Bicycle Therapeutics Announces Significant Progress Across Multiple Therapeutic Programs Beyond Oncology March 31, 2021
Pyxis Oncology Closes $152 Million Series B Financing to Further Advance Portfolio of Biologics March 30, 2021
Lassen Therapeutics Announces Collaboration with Cedars Sinai Medical Center to Study the Role of IL-11 Signaling and Inhibition in Preclinical Models of Lung Fibrosis March 25, 2021
XyloCor Therapeutics Completes Oversubscribed $41.9 Million Series A Financing To Advance Novel Gene Therapy Pipeline For Coronary Artery Disease March 25, 2021
Pyxis Oncology Announces Worldwide Licensing Agreement with Pfizer to Develop and Commercialize Multiple Antibody-Drug Conjugates March 25, 2021
Be Bio Announces Appointment of Cell and Gene Therapy Veterans Joanne Smith-Farrell, Ph.D., as Chief Executive Officer and Rick Morgan, Ph.D., as Chief Scientific Officer March 18, 2021
